Safety and tolerability of the NE inhibitor BAY 85-8501 in patients with non-CF bronchiectasis - London 2016

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses London 2016

Preclinical pharmacology: drug targets and mechanisms of action

Chair(s): Chantal Donovan (Newcastle, NSW, Australia), Martina Schmidt (Groningen, Netherlands), Fu-Qiang Wen (Chengdu, Sichuan, China)

Session type: Thematic Poster

Safety and tolerability of the NE inhibitor BAY 85-8501 in patients with non-CF bronchiectasis

Henrik Watz (Grosshansdorf, Germany), Henrik Watz, Frauke Pedersen, Anne Kirsten, Johannes Nagelschmitz, Tiemo-Jörg Bandel, Stephan Schwers, Klaus Rabe

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

CDN Connection Issue

The ERS International Congress 2016, London

Limited Access

#{title}